The Correlation Between MicroRNA490-3p and TGFα in Endometrial Carcinoma Tumorigenesis and Progression
Overview
Affiliations
MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate the translation of messenger RNAs by binding their 3'-untranslated region (3' UTR). MiR-490-3p has been reported to be a suppressor in various human cancers; however, little is known about the biological functions of miR-490-3p in endometrial cancer (EC). In our study, we found that MiR-490-3p mRNA expression was significantly lower in ECs than in normal endometrial tissues. MiR-490-3p mRNA expression was also negatively associated with depth of invasion (mucosa vs. muscular and serosa) and lymph node metastasis (negative vs. positive) in EC. MiR-490-3p overexpression reduced proliferation; promoted G1 arrest and apoptosis; suppressed migration and invasion; and reduced TGFα, NF-kB, cyclin D1, survivin, matrix metalloproteinase 2 (MMP2) mRNA and protein expression, and improved Bax mRNA and protein expression. The dual-luciferase reporter assay indicated that miR-490-3p directly targeted TGFα by binding its 3' untranslated region. MiR-490-3P transfection also suppressed tumor development and TGFα expression (as determined by immunohistochemistry and western blotting) in vivo in the xenograft mouse model. This is the first demonstration that miR-490-3P might act as a suppressor in EC tumorigenesis and progression by targeting TGFα. Our results provide a theoretical basis for the further study on the molecular target for endometrial cancer.
MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?.
Li Y, Tian D, Chen H, Cai Y, Chen S, Duan S Oncol Lett. 2021; 22(3):678.
PMID: 34345303 PMC: 8323007. DOI: 10.3892/ol.2021.12939.
Klicka K, Grzywa T, Klinke A, Mielniczuk A, Wlodarski P Cancers (Basel). 2021; 13(14).
PMID: 34298609 PMC: 8304659. DOI: 10.3390/cancers13143393.
Curcumin anti-tumor effects on endometrial cancer with focus on its molecular targets.
Jahanbakhshi F, Dana P, Badehnoosh B, Yousefi B, Mansournia M, Jahanshahi M Cancer Cell Int. 2021; 21(1):120.
PMID: 33602218 PMC: 7891161. DOI: 10.1186/s12935-021-01832-z.
Wang Y, He R, Ma L Front Bioeng Biotechnol. 2020; 8:266.
PMID: 32426332 PMC: 7212445. DOI: 10.3389/fbioe.2020.00266.
Yang H, Zhang L, Wang X, Huang M, Lin P, Pang Y Int J Clin Exp Pathol. 2020; 11(3):1123-1134.
PMID: 31938207 PMC: 6958166.